Megan Paulette Rosales Nacar, VP of commercial at DeciBio, is a leader in precision medicine and oncology, driving commercial ...

In a study involving 43 MBC patients, the liquid biopsy test reclassified three out of five patients who were initially deemed HER2-negative by tissue biopsy as HER2-positive. This discovery ...

PanGIA Biotech–a pioneer in liquid biopsy technology–today announced its first international partnership, collaborating with Canary Oncoceutics (Canar ...

Payers want to make sure patients are getting biopsies done so they can get on the right therapies, said Bhuvana Sagar, MD, Oncology Consultants.

This eBook delves into the science behind first-void urine, exploring its composition, collection methods, and the latest ...